Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
7.79
+1.41 (22.10%)
At close: Mar 27, 2026, 4:00 PM EDT
7.58
-0.21 (-2.70%)
After-hours: Mar 27, 2026, 7:58 PM EDT

Polaryx Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
---0.10
Net Debt / Equity Ratio
-1.13-1.13-0.980.10
Quick Ratio
8.508.5015.990.00
Current Ratio
8.558.5517.302.23
Return on Equity (ROE)
-193.70%-193.70%-1013.73%-
Return on Assets (ROA)
-96.12%-96.12%-74.36%-
Return on Capital Employed (ROCE)
-171.30%-171.30%-92.40%-296.10%
Buyback Yield / Dilution
-32.81%-32.81%-219.94%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q